- Home
- PAA vs ASND Comparison
PAA vs ASND Comparison
Compare PAA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAA | ASND |
|---|---|---|
| Founded | 1981 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 12.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | PAA | ASND |
|---|---|---|
| Price | $17.75 | $205.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 15 |
| Target Price | $20.40 | ★ $256.27 |
| AVG Volume (30 Days) | ★ 2.4M | 640.2K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | ★ 8.57% | N/A |
| EPS Growth | ★ 8.03 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $46,917,000,000.00 | $758,592,045.00 |
| Revenue This Year | N/A | $99.74 |
| Revenue Next Year | $3.43 | $79.40 |
| P/E Ratio | $17.11 | ★ N/A |
| Revenue Growth | N/A | ★ 97.46 |
| 52 Week Low | $15.58 | $118.03 |
| 52 Week High | $21.00 | $223.19 |
Technical Indicators
Market Signals| Indicator | PAA | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 69.45 | 49.03 |
| Support Level | $16.73 | $198.30 |
| Resistance Level | $17.60 | $218.50 |
| Average True Range (ATR) | 0.27 | 9.16 |
| MACD | 0.08 | -0.64 |
| Stochastic Oscillator | 81.93 | 28.05 |
Price Performance
Historical ComparisonAbout PAA Plains All American Pipeline L.P.
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.